{
    "clinical_study": {
        "@rank": "125982", 
        "arm_group": [
            {
                "arm_group_label": "Pazopanib", 
                "arm_group_type": "Experimental", 
                "description": "pazopanib maintenance after 4 cycles of etoposide/platinum in SCLC"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo after 4 cycles of etoposide/platinum chemotherapy in SCLC"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the efficacy of pazopanib maintenance after 1st line CTx for SCLC."
        }, 
        "brief_title": "Pazopanib Maintenance for SCLC", 
        "condition": "SCLC", 
        "condition_browse": {
            "mesh_term": "Small Cell Lung Carcinoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histologically confirmed SCLC\n\n          -  no disease progression after 4 cycles of etoposide/platinum 1st-line therapy\n\n          -  history of 4 cycles of etoposide/platinum 1st-line therapy\n\n          -  between 21 days and 42 days since C4D1 of etoposide/platinum\n\n          -  no symptomatic brain meta\n\n        Exclusion Criteria:\n\n          -  poor hepatic, renal function"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01797874", 
            "org_study_id": "2012-09-060-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pazopanib", 
                "description": "Experimental", 
                "intervention_name": "pazopanib", 
                "intervention_type": "Drug", 
                "other_name": "For patients without progressive disease after 4 cycles of Etoposide/platinum therapy, pazopanib maintenance will be administered."
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "placebo arm", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Etoposide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pazopanib maintenance", 
            "efficacy"
        ], 
        "lastchanged_date": "March 11, 2014", 
        "location": {
            "contact": {
                "email": "silkahn@skku.edu", 
                "last_name": "Myung-Ju Ahn, Ph.D.", 
                "phone": "822-3410-1795"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "135-710"
                }, 
                "name": "Samsung Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase II Study of Pazopanib Maintenance for SCLC", 
        "overall_contact": {
            "email": "silkahn@skku.edu", 
            "last_name": "Myung-Ju Ahn, Ph.D.", 
            "phone": "822-3410-1795"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Progression-free survival", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01797874"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Samsung Medical Center", 
            "investigator_full_name": "Myung-Ju Ahn", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Samsung Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Samsung Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}